Skip to main content
Clinical Trials/NCT04339686
NCT04339686UnknownNot Applicable

Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening. Comparison to Virological Testing and Multiparametric Gold Standard

Poitiers University Hospital1 site in 1 country56,000 target enrollmentStarted: April 20, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
56,000
Locations
1
Primary Endpoint
Diagnostic performance of chest CT in screening for pulmonary lesions in clinical suspicions of COVID.

Study Overview

Brief Summary

All patients included in this search will be on anonymized file: Symptomatic patients consulting for suspicion of COVID 19 with indication to a screening (RT-PCR, Scanner) according to the criteria of the Ministry of Health.

To evaluate the diagnostic performance of chest CT in screening for COVID-related lung injury in patients with a clinical suspicion of COVID.

CT scan results for COVID according to French thoracic imaging society will be dichotomized into evocative or compatible (considered positive) non-evocative (considered negative) The results will be compared to the gold standard corresponding to a multiparametric element: the discharge summary.

Ct Scan performance will be recorded and analyzed.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All patients suspected of COVID 19 consulting for diagnostic

Exclusion Criteria

  • Delay between RT-PCR and Thoracic Scan greater than 6 days.

Outcomes

Primary Outcomes

Diagnostic performance of chest CT in screening for pulmonary lesions in clinical suspicions of COVID.

Time Frame: 1 month

CT Report will dichotomized into evocative or non-evocative for COVID-related lung injury.

Secondary Outcomes

  • Compare the diagnostic performance of chest CT and RT-PCR in COVID 19 at the initial consultation (screening).(1 month)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials